Holen Sie sich die Stockscreener-App
15.80
5.45%
-0.91
Handel nachbörslich:
14.90
-0.90
-5.70%
Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | 0.192 | 0.249 |
| Costs And Expenses |
0.61%
19.20
|
19.32 | 14.67 | 13.50 | 13.11 |
| Operating Income/Loss |
0.61%
-19.20
|
-19.32 | -14.67 | -13.31 | -12.86 |
| Nonoperating Income/Loss |
696.65%
-11.42
|
-1.433 | 1.528 | -21.91 | 35.88 |
| Income/Loss From Continuing Operations Before Tax |
47.54%
-30.61
|
-20.75 | -13.14 | -35.23 | 23.02 |
| Income Tax Expense/Benefit, Deferred |
37.50%
0.01
|
0.016 | 0.008 | 0.114 | -0.014 |
| Income Tax Expense/Benefit |
31.25%
0.011
|
0.016 | 0.008 | 0.114 | -0.014 |
| Income/Loss From Continuing Operations After Tax |
47.48%
-30.62
|
-20.77 | -13.15 | -35.34 | 23.04 |
Net Income/Loss
|
47.48%
-30.62
|
-20.77 | -13.15 | -35.34 | 23.04 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | -0.177 | 17.57 |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
29.28%
14.00
|
10.83 | 10.51 | 1.935 | 5.5463 |
| Diluted Average Shares |
29.28%
14.00
|
10.83 | 10.51 | 0.9554 | 10.78 |
| Basic Earnings Per Share |
14.06%
-2.19
|
-1.92 | -1.25 | -7.95 | 0.98 |
| Diluted Earnings Per Share |
14.06%
-2.19
|
-1.92 | -1.25 | 1.72 | -2.83 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | -0.354 | 35.15 |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):